AB
NGNE icon

Amalgamated Bank’s Neurogene NGNE Stock Holding History

Amalgamated Bank’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-309
Closed -$6K – 2396
2025
Q4 		$6K Sell
309
-47
-13% -$1.17K ﹤0.01% 2656
2025
Q3 		$6K Hold
356
– – ﹤0.01% 2687
2025
Q2 		$5K Hold
356
– – ﹤0.01% 2766
2025
Q1 		$4K Hold
356
– – ﹤0.01% 2727
2024
Q4 		$8K Hold
356
– – ﹤0.01% 2555
2024
Q3 		$15K Hold
356
– – ﹤0.01% 2258
2024
Q2 		$13K Buy
+356
New +$12.6K ﹤0.01% 2314
2022
Q2 		– Sell
-231
Closed -$9K – 3144
2022
Q1 		$9K Buy
+231
New +$13.5K ﹤0.01% 2976

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Amalgamated Bank's NGNE Position: Q1 2026 in Review

Amalgamated Bank sold out of Neurogene (NGNE) in Q1 2026, closing a stake of 309 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in NGNE in Q1 2022 and held it in 8 quarters. The position peaked at $15K in Q3 2024. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Amalgamated Bank reported no remaining Neurogene position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 309 Neurogene shares in Q1 2026, an estimated $6K.
  • Amalgamated Bank first reported a position in Neurogene in Q1 2022 and held it in 8 quarters.
  • Amalgamated Bank's Neurogene position peaked at $15K in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.